文献速递心脑血管急症重症综合管理与镇静镇痛

被临床医生预测无望有意义恢复的卒中患者长期结局:日本队列研究

Long-Term Outcomes of Patients with Stroke Predicted by Clinicians to have no Chance of Meaningful Recovery: A Japanese Cohort Study.
PubMed 文献 · Neurocrit Care · 2022-11-30
一句话结论在较少撤销生命支持治疗的日本,伤后1-4天被预测无望有意义恢复的昏迷卒中患者中,约半数6个月时死亡,少数获得良好功能恢复。

该研究回顾性分析了日本一家神经重症监护病房2018年1月至2020年12月收治的急性缺血性卒中、脑出血或非创伤性蛛网膜下腔出血患者,筛选出伤后1-4天被主治医生预测无望有意义恢复的40例患者(缺血性卒中14例、脑出血19例、蛛网膜下腔出血7例)。主要结局为出院去向及伤后6个月评估的遵嘱能力和GOS-E功能结局。6个月时17例死亡,14例住在长期护理医院;3例可可靠遵嘱,1例独立并能够恢复工作类活动(GOS-E 5)。结论指出,在未撤销生命支持治疗的情况下,近半数被预测无望恢复的患者6个月时死亡,少数患者获得良好功能恢复,提示需要更准确的神经预后评估。

要点

  • 纳入40例伤后1-4天被主治医生预测无望有意义恢复的昏迷卒中患者(缺血性卒中14例、脑出血19例、蛛网膜下腔出血7例),中位年龄77岁。
  • 6个月时17例死亡(42.5%),14例住在长期护理医院,3例住家中,2例住康复中心,2例住养老院。
  • 6个月时仅3例可可靠遵嘱;2例处于植物状态(GOS-E 2),4例完全依赖他人(GOS-E 3),1例可独立独处8小时但仍依赖(GOS-E 4),1例独立并能够恢复工作类活动(GOS-E 5)。
  • 在未撤销生命支持治疗的日本,早期预测无望恢复并不等于必然死亡,少数患者可获得良好功能恢复,提示需要更准确的神经预后评估。

适用人群与场景

  • 2018年1月至2020年12月入住日本埼玉县Toda Medical Group Asaka Medical Center神经重症监护病房的急性缺血性卒中、脑出血或非创伤性蛛网膜下腔出血患者。
  • 纳入标准:主治医生在伤后第1-4天预测无望有意义恢复。
  • 共筛选860例患者,识别出40例符合条件者。

研究设计与关键结果

  • 回顾性队列研究,纳入40例被预测无望有意义恢复的昏迷卒中患者(缺血性卒中14例、脑出血19例、蛛网膜下腔出血7例),中位年龄77岁(四分位距64-85),53%(n=21)为女性,80%(n=32)入院前无功能缺陷。
  • 6个月时17例死亡,14例住在长期护理医院,3例住家中,2例住康复中心,2例住养老院。
  • 6个月时3例可可靠遵嘱;2例处于植物状态(GOS-E 2),4例完全依赖他人且需要持续帮助(GOS-E 3),1例可独立独处8小时但仍依赖(GOS-E 4),1例独立并能够恢复工作类活动(GOS-E 5)。

证据类型、等级与局限

  • 回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在未撤销生命支持治疗的日本,伤后1-4天被预测无望有意义恢复的昏迷卒中患者中,近半数6个月时死亡,少数获得良好功能恢复;作者认为这凸显了需要更准确的神经预后评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Little is known about the natural history of comatose patients with brain injury, as in many countries most of these patients die in the context of withdrawal of life-sustaining therapies (WLSTs). The accuracy of predicting recovery that is used to guide goals-of-care decisions is uncertain. We examined long-term outcomes of patients with ischemic or hemorrhagic stroke predicted by experienced clinicians to have no chance of meaningful recovery in Japan, where WLST in patients with isolated neurological disease is uncommon.

METHODS: We retrospectively reviewed the medical records of all patients admitted with acute ischemic stroke, intracerebral hemorrhage, or nontraumatic subarachnoid hemorrhage between January 2018 and December 2020 to a neurocritical care unit at Toda Medical Group Asaka Medical Center in Saitama, Japan. We screened for patients who were predicted by the attending physician on postinjury day 1-4 to have no chance of meaningful recovery. Primary outcome measures were disposition at hospital discharge and the ability to follow commands and functional outcomes measured by the Glasgow Outcome Scale-Extended (GOS-E), which was assessed 6 months after injury.

RESULTS: From 860 screened patients, we identified 40 patients (14 with acute ischemic stroke, 19 with intracerebral hemorrhage, and 7 with subarachnoid hemorrhage) who were predicted to have no chance of meaningful recovery. Median age was 77 years (interquartile range 64-85), 53% (n = 21) were women, and 80% (n = 32) had no functional deficits prior to hospitalization. Six months after injury, 17 patients were dead, 14 lived in a long-term care hospital, 3 lived at home, 2 lived in a rehabilitation center, and 2 lived in a nursing home. Three patients reliably followed commands, two were in a vegetative state (GOS-E 2), four fully depended on others and required constant assistance (GOS-E 3), one could be left alone independently for 8 h per day but remained dependent (GOS-E 4), and one was independent and able to return to work-like activities (GOS-E 5).

CONCLUSIONS: In the absence of WLST, almost half of the patients predicted shortly after the injury to have no chance of meaningful recovery were dead 6 months after the injury. A small minority of patients had good functional recovery, highlighting the need for more accurate neurological prognostication.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Egawa S, Ader J, Shen Q, et al. Long-Term Outcomes of Patients with Stroke Predicted by Clinicians to have no Chance of Meaningful Recovery: A Japanese Cohort Study. Neurocrit Care. 2022. PMID: 36450972. doi:10.1007/s12028-022-01644-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。